The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Addictive Behaviours

• Publication date

  2010-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.addbeh.2009.09.004PMID 19836144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

  2008cited by this paper
• Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials.

  2007cited by this paper
• Antidepressants for smoking cessation.

  2007cited by this paper
• CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

  2007cited by this paper
• Responses to positive and negative smoking-related images: effects of current smoking status and degree of smoking addiction.

  2005cited by this paper
• Imagery-induced tobacco craving: duration and lack of assessment reactivity bias.

  2004cited by this paper
• Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.

  2004cited by this paper
• Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.

  2002cited by this paper
• Nicotine patches and the subjective effects of cigarette smoking: a pilot study.

  2002cited by this paper
• The effect of bupropion sustained-release on cigarette craving after smoking cessation.

  2002cited by this paper
• Brain metabolic changes during cigarette craving.

  2002cited by this paper
• Mediating mechanisms for the impact of bupropion in smoking cessation treatment.

  2002cited by this paper
• Bupropion is a nicotinic antagonist.

  2000cited by this paper
• The effect of bupropion on nicotine craving and withdrawal

  2000cited by this paper
• CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

  2000cited by this paper
• Drug anticipation and drug addiction. The 1998 H. David Archibald Lecture.

  1999cited by this paper
• Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

  1999cited by this paper
• A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

  1999cited by this paper
• Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

  1998cited by this paper
• A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation

  1997cited by this paper
• A comparison of sustained-release bupropion and placebo for smoking cessation.

  1997cited by this paper
• Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.

  1994cited by this paper
• The development and initial validation of a questionnaire on smoking urges.

  1991cited by this paper
• Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

  1988cited by this paper
• Development and validation of brief measures of positive and negative affect: the PANAS scales.

  1988cited by this paper

• Cue-reactivity targeted smoking cessation intervention in individuals with tobacco use disorder: a scoping review

  2023cites this paper
• Antidepressants for smoking cessation

  2023cites this paper
• Effects of varenicline and bupropion on laboratory smoking outcomes: Meta‐analysis of randomized, placebo‐controlled human laboratory studies

  2022cites this paper
• Antidepressants for smoking cessation.

  2020cites this paper
• Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development

  2019cites this paper
• Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential

  2019cites this paper
• A Procedure to Standardize Puff Topography During Evaluations of Acute Tobacco or Electronic Cigarette Exposure.

  2018cites this paper
• Interventions to reduce harm from continued tobacco use.

  2016cites this paper
• Antidepressants for smoking cessation.

  2014cites this paper
• Goal-directed and transfer-cue-elicited drug-seeking are dissociated by drug preload : Evidence for independent additive controllers

  2014cites this paper
• Smoking behaviour and compensation: a review of the literature with meta-analysis.

  2014cites this paper
• Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers.

  2013cites this paper
• The Cue Reactivity Paradigm in Addiction Research

  2013cites this paper
• Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study

  2013cites this paper
• Feasibility of Using Virtual Reality to Assess Nicotine Cue Reactivity During Treatment

  2012cites this paper
• Goal-directed and transfer-cue-elicited drug-seeking are dissociated by pharmacotherapy: evidence for independent additive controllers.

  2012cites this paper
• Translational research in addiction: toward a framework for the development of novel therapeutics.

  2011cites this paper
• Effect of Varenicline vs. Placebo on Reactivity to Tobacco and Alcohol Cues in Smokers who are Light Drinkers

  2011cites this paper
• Effects of Varenicline on Cue-reactivity in Individuals with Concurrent Tobacco Dependence and Heavy Alcohol Use: A Randomized, Double-blind, Placebo-controlled Trial

  2010cites this paper